Ballentine Partners LLC Purchases 12 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Ballentine Partners LLC increased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 2.3% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 527 shares of the medical instruments supplier’s stock after buying an additional 12 shares during the period. Ballentine Partners LLC’s holdings in Mettler-Toledo International were worth $702,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. QRG Capital Management Inc. bought a new position in shares of Mettler-Toledo International in the 3rd quarter worth $342,000. LPL Financial LLC lifted its stake in Mettler-Toledo International by 31.0% during the third quarter. LPL Financial LLC now owns 3,956 shares of the medical instruments supplier’s stock worth $4,384,000 after purchasing an additional 936 shares during the last quarter. Mariner LLC raised its holdings in shares of Mettler-Toledo International by 6.5% during the 3rd quarter. Mariner LLC now owns 8,030 shares of the medical instruments supplier’s stock valued at $8,898,000 after buying an additional 489 shares in the last quarter. Stifel Financial Corp lifted its position in Mettler-Toledo International by 4.7% in the 3rd quarter. Stifel Financial Corp now owns 8,616 shares of the medical instruments supplier’s stock worth $9,547,000 after buying an additional 386 shares during the last quarter. Finally, Federated Hermes Inc. boosted its stake in Mettler-Toledo International by 18.4% in the third quarter. Federated Hermes Inc. now owns 6,557 shares of the medical instruments supplier’s stock worth $7,266,000 after buying an additional 1,017 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Trading Up 0.0 %

NYSE MTD traded up $0.52 during trading hours on Monday, hitting $1,464.00. 3,649 shares of the company’s stock traded hands, compared to its average volume of 142,310. Mettler-Toledo International Inc. has a 52 week low of $928.49 and a 52 week high of $1,535.86. The business’s fifty day moving average price is $1,378.56 and its two-hundred day moving average price is $1,283.46. The firm has a market capitalization of $31.27 billion, a P/E ratio of 40.87, a P/E/G ratio of 3.91 and a beta of 1.20.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $8.89 EPS for the quarter, beating the consensus estimate of $7.61 by $1.28. Mettler-Toledo International had a net margin of 20.55% and a negative return on equity of 662.32%. The firm had revenue of $925.95 million for the quarter, compared to the consensus estimate of $879.72 million. During the same period last year, the firm earned $8.69 EPS. The company’s revenue was down .3% on a year-over-year basis. On average, sell-side analysts expect that Mettler-Toledo International Inc. will post 40.13 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $1,528.43, for a total value of $458,529.00. Following the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at $7,510,705.02. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Thomas P. Salice sold 1,268 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $1,490.18, for a total transaction of $1,889,548.24. Following the transaction, the director now directly owns 244 shares in the company, valued at approximately $363,603.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $1,528.43, for a total transaction of $458,529.00. Following the completion of the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at approximately $7,510,705.02. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 3,278 shares of company stock valued at $4,871,849. Corporate insiders own 1.94% of the company’s stock.

Analysts Set New Price Targets

MTD has been the subject of a number of recent research reports. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Monday, April 29th. Evercore ISI lifted their target price on shares of Mettler-Toledo International from $1,200.00 to $1,300.00 and gave the stock an “in-line” rating in a research note on Thursday, April 4th. Robert W. Baird raised their price target on shares of Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the stock a “neutral” rating in a report on Monday, May 13th. Jefferies Financial Group reaffirmed an “underperform” rating and set a $1,250.00 price objective (up from $1,230.00) on shares of Mettler-Toledo International in a research note on Monday, June 3rd. Finally, Citigroup upped their price target on Mettler-Toledo International from $975.00 to $1,200.00 and gave the company a “sell” rating in a research report on Monday, May 13th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and an average price target of $1,256.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.